Inventiva (IVEVF) Current Assets (2018 - 2025)
Inventiva (IVEVF) posted Current Assets of $284.6 million for Q4 2025, up 45.48% on a QoQ basis from $195.6 million in Q2 2025, and up 138.82% year-over-year from $119.2 million in Q4 2024.
Analysis
Inventiva (IVEVF) Current Assets (2018 - 2025) Analysis & Trends
Inventiva has reported Current Assets for 8 years, with the latest figure at $284.6 million in Q4 2025.
- On a quarterly basis, Current Assets rose 138.82% year-over-year to $284.6 million in Q4 2025; TTM through Dec 2025 was $284.6 million, a 138.82% increase from a year earlier, with the FY2025 full-year figure at $284.6 million, up 138.82% from the prior year.
- Current Assets was $284.6 million for Q4 2025 at Inventiva, up from $195.6 million in the prior quarter.
- The five-year high for Current Assets was $284.6 million in Q4 2025, with the low at $2.2 million in Q2 2024.
- Average Current Assets over 5 years is $121.9 million, with a median of $119.2 million recorded in 2024.
- The sharpest annual moves came in 2024 and 2025: Current Assets slumped 96.19% in 2024, then surged 8914.82% in 2025.
- Over 5 years, Current Assets stood at $132.2 million in 2021, then fell by 17.91% to $108.5 million in 2022, then slumped by 52.23% to $51.8 million in 2023, then jumped by 129.82% to $119.2 million in 2024, then jumped by 138.82% to $284.6 million in 2025.
- The last three Current Assets figures came in at $284.6 million (Q4 2025), $195.6 million (Q2 2025), and $119.2 million (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.71 Bn | 625.95 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 442.22 Bn | 435.65 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 366.92 Bn | 359.78 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 266.90 Bn | 259.21 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn | 41.36 Bn |
| 6 | Sanofi | 52.44 Bn | 45.06 Bn | 10.79 Bn | 36.64 Bn |
| 7 | Revolution Medicines | 44.11 Bn | 44.11 Bn | - | 4.03 Bn |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | 6.03 Bn |
| 9 | United Therapeutics | 21.50 Bn | 18.84 Bn | 683.80 Mn | 3.48 Bn |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - | 284.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 284.57 Mn |
| Jun 30, 2025 | 195.62 Mn |
| Dec 31, 2024 | 119.16 Mn |
| Jun 30, 2024 | 2.17 Mn |
| Dec 31, 2023 | 51.85 Mn |
| Jun 30, 2023 | 57.03 Mn |
| Dec 31, 2022 | 108.54 Mn |
| Jun 30, 2022 | 106.63 Mn |
| Dec 31, 2021 | 132.22 Mn |
| Jun 30, 2021 | 132.26 Mn |
| Mar 31, 2021 | 151.28 Mn |
| Dec 31, 2020 | 158.57 Mn |
| Jun 30, 2020 | 66.27 Mn |
| Dec 31, 2019 | 54.10 Mn |
| Dec 31, 2018 | 81.76 Mn |